Risk of Free Flap Failure in Head and Neck Reconstruction - Analysis of 21,548 Cases From A Nationwide Database

Abstract

Background: Head and neck reconstruction is complicated, and is made even more challenging by free flap failure. We identified risk factors associated with free flap failure in records extracted from a nationwide database of a 23 million population.

Methods: We used ICD-9 (International Classification of Diseases, Ninth Revision) codes 140–149 and 161 to identify patients in Taiwan’s National Health Insurance Research Database (NHIRD) with head and neck cancer between 2000 to 2013. Patient age, gender, neoadjuvant treatment, comorbidities, and anticoagulation use were also retrieved. Free flap reconstruction twice, or free flap and pedicle flap reconstructions during the same hospitalization was recorded as free flap failure. Logistic regression was used to identify factors that increased risk of free flap failure.

Results: A total of 21,548 patients with head and neck cancer were identified; 883 (4.1%) experienced free flap failure. Use of aspirin, clopidogrel, urokinase, prostaglandin (PGE1), low-molecular-weight heparin (LMWH), and operation time significantly increased the risk of free flap failure. However, some potential cofounders could not be identified from the database.

Conclusions: Several statistically significant findings were prone to influence by potential confounders. The only interpretable and clinically applicable result was that longer operation time and preoperative chemotherapy significantly increased the likelihood of free flap failure.